Introduction
Many studies have demonstrated the benefits of exercise in preventing all-cause mortality, including cardiovascular disease, metabolic disease, and cancer. [1] [2] [3] Exercise reduces the risk of death by preventing metabolic diseases and protects against chronic diseases. Organ-to-organ crosstalk involving muscle contraction at the molecular level is emerging as a field related to exercise. 4 Additionally, adipokines are identified as hormones that mediate crosstalk between adipose tissue and brain, as well as metabolic functions during the activation cytokines or peptides produced and secreted during skeletal muscle contraction. The classified these cytokine and peptides as myokines. Furthermore, numerous studies demonstrated that myokines are exercise induced. [8] [9] [10] The most well-known exercise-induced myokine interleukin (IL)-6 was the first myokine to be identified in the bloodstream in response to muscle contractions. 11 IL-6 is a peptide that plays an antiinflammatory role by inhibiting tumor necrosis factor-␣; it also improves glucose uptake by stimulating AMP-activated protein kinase (AMPK) signaling. [12] [13] [14] Surprisingly, circulating IL-6 levels are increased during exercise without any sign of muscle damage. 15 Myokines likely provide beneficial metabolic effects during crosstalk between skeletal muscle and liver, and skeletal muscle and adipose tissue. [16] [17] [18] Additionally, several studies demonstrated that exercise-induced myokines have positive effects on glucose uptake, 19, 20 glucose tolerance, 21 regulation of fat oxidation, 11, 21 and satellite cell proliferation. 22, 23 Myokines, as one of multiple health factors, constitute an important area of research in metabolic diseases. 24, 25 This review summarizes the potential positive effects of exerciseinduced myokines, such as IL-15, brain-derived neurotrophic factor (BDNF), leukemia inhibitory factor (LIF), irisin, fibroblast growth factor 21 (FGF-21), and secreted protein acidic and rich in cysteine (SPARC), on metabolic diseases ( Fig. 1 and Table 1 ).
2.
Interleukin-15
IL-15 may play a role not only in muscle-fat interaction, but also in skeletal muscle fiber growth. 26 IL-15, a member of the IL-2 superfamily, activates its functions through the ␤ and ␥ chains of the IL-2 receptor. 27, 28 Quinn et al 29 showed that IL-15 can stimulate differentiated myocytes and muscle fibers to accumulate increased amounts of contractile proteins in skeletal muscle. Additionally, IL-15 stimulates muscle-specific myosin heavy-chain accumulation in differentiated myocytes and muscle fibers in culture. 29, 30 Among its various roles, IL-15 has been demonstrated to regulate metabolic diseases, such as obesity and diabetes. 21 IL-15 modulates glucose uptake in incubated skeletal muscle and muscle cell cultures. 31 These results suggested that IL-15 may prevent the development of diabetes. 26 Busquets et al 19 showed that in vivo administration of IL-15 increased glucose uptake in skeletal muscle and in vitro IL-15 treatment increased glucose transporter type 4 mRNA content in C2C12 cells. These findings indicate that IL-15 may be an important mediator (regulator) of skeletal muscle fiber growth, hypertrophy, and glucose uptake. Numerous studies demonstrated that exercise alters IL-15 concentration in serum or at the mRNA level. The most noticeable change in serum IL-15 was observed after moderate-intensity resistance training. 32, 33 Other studies showed that aerobic training increased IL-15 in human and rodent serum and at the mRNA level. 34, 35 Given that IL-15 controls glucose and lipid metabolism, it may have an important role in controlling metabolic diseases, including obesity and type 2 diabetes. However, studies on IL-15 expression in the skeletal muscle and plasma after exercise showed inconsistent results. It is evident that after resistance exercise, IL-15 protein level increases in the plasma 32, 33 ; however, mRNA levels of IL-15 decrease after 2 hours of intensive strength training. 36 In addition, circulating levels of IL-15 were increased in healthy young men, but remained unchanged after a single bout of treadmill running. 37 Treadmill exercise increased IL-15 expression in the skeletal muscle of high-fatinduced obese rats. 35 Similar treadmill exercise conducted in our laboratory showed an increase of IL-15 expression in the soleus muscle of a transgenic diabetic Zucker rat. Our data also demonstrated that treadmill exercise improved glucose tolerance in the Zucker rat. 38 In addition, 1 hour of acute exercise increased IL-15 expression in Sprague-Dawley rats. 39 These data collectively suggest that exercise-induced IL-15 may be important for the modulation of glucose uptake and improved glucose tolerance. While the role of IL-15 in treating metabolic diseases, such as obesity and type 2 diabetes, has now been revealed, further investigation on changes in IL-15 and its potential role is required.
3.
Brain-derived neurotrophic factor
Neurotrophins are well-known regulators of various neuronal processes and act primarily through tropomyosin-related kinase receptor tyrosine kinases. The mammalian family of neurotrophins consists of nerve growth factor, neurotrophin-3, neurotrophin-4/5, and BDNF. Among these neurotrophins, BDNF and its receptor tropomyosin-related kinase B are most widely and abundantly expressed in the brain. 40 To date, numerous studies suggested that BDNF may play a role not only in central metabolic pathways, but also as a metabolic regulator of skeletal muscle. Wisse and Schwartz 41 reported that BDNF is a key modulator of the hypothalamic pathway that controls body composition and energy homeostasis. BDNF is a regulator of metabolism in skeletal muscle 42 and an enhancer of glucose utilization in diabetic skeletal muscle. 43 Current studies demonstrated that BDNF reduces food intake and lowers blood glucose level in genetically modified (db/db) obese mice, suggesting that BDNF plays a role in energy balance and insulin signaling. [44] [45] [46] In addition, a recent study suggested that gene transfer of BDNF has therapeutic efficacy in mouse models of obesity and diabetes. 47 It is now known that BDNF is expressed in nonneurogenic tissues, including skeletal muscle. Animal studies demonstrated that BDNF mRNA increases in skeletal muscle in response to contraction. 48, 49 Numerous studies showed that BDNF mRNA and protein expression were increased in human skeletal muscle after exercise; however, skeletal muscle-derived BDNF was not released into circulation. 42 Additionally, BDNF increased phosphorylation of AMPK and acetyl-CoA carboxylase-beta, and enhanced fat oxidation. Based on recent research evidence, BDNF appears to be a myokine that acts in an autocrine or paracrine fashion with strong effects on peripheral metabolism, including fat oxidation, and a subsequent effect on the size of adipose tissue. 50 Skeletal muscle BDNF was reported as a key modulator in metabolic diseases, including type 2 diabetes mellitus. In previous studies about diabetes and BDNF, increased BDNF mRNA in the soleus muscle of diabetic rats compared to age-matched controls indicated that elevated BDNF may protect the distal nerve from the denervated muscle of diabetic rat. 51, 52 Our unpublished data also showed an increased BDNF expression in the soleus muscle of type 2 diabetes mellitus-induced rats as compared to the lean controls. We also found significant decreases in BDNF expression following resistance exercise in the soleus, tibialis anterior, and extensor digitorum longus muscles. BDNF in skeletal muscle may be expressed as a compensatory neurotrophic factor against diabetic neuropathy or myopathy.
Although the important role of BDNF in peripheral metabolism including skeletal muscle metabolism is well known, the role of BDNF expression in diabetic skeletal muscle with severe glucose tolerance is not fully established. Moreover, considering the role of BDNF in skeletal muscle, further research is required to investigate the effect of physical exercise and nutritional treatment on BDNF expression and its potential to improved glucose metabolism in diabetic skeletal muscle.
Leukemia inhibitory factor
LIF is known as an important player in skeletal muscle hypertrophy and regeneration by enhancing cell proliferation though the common signaling mediators janus kinase (JAK), signal transducer and activator of transcription-3 (STAT3), and phosphoinositide-3-kinase. [53] [54] [55] [56] Previous studies showed that LIF mRNA is upregulated exogenously after muscle injury, including muscle crush and contusion injury. 57 LIF is a newly discovered myokine 23 ; it is produced by skeletal muscle and affects intact muscles, as well as isolated muscle cells. 58, 59 Among its various roles, the most important role of LIF in muscle satellite cell is proliferation for proper muscle hypertrophy and regeneration. 23 Although studies on exercise-related LIF expression remained controversial, LIF mRNA levels increased after a single bout of both cycle ergometer exercise 58 and heavy resistance exercise 59 in the human vastus lateralis muscle, whereas LIF protein levels were not significantly changed. Since LIF has a very short half-life of 6-8 minutes in serum, it is difficult to detect circulating levels of LIF protein. 60 Moreover, LIF promotes survival of myoblasts in dystrophic muscle; however, LIF mRNA levels were found to decrease after 2 weeks of voluntary wheel running in mdx mice. 61 Numerous studies demonstrated that LIF clearly has the potential to regulate skeletal muscle disease, including muscular dystrophy, and it furthermore promotes myoblast survival in dystrophic muscle. 61 These studies suggested that LIF provides alternative therapeutic ways to stimulate skeletal muscle regeneration in an autocrine or paracrine fashion after injury. However, the duration of increased LIF mRNA and protein levels after exercise is not well known. Further investigation is needed to describe the relationships between alteration of LIF mRNA, and protein levels and exercise duration or type. 
Irisin
Irisin is a peroxisome proliferator-activated receptor-␥ coactivator-1␣ (PPAR-␥) coactivator-1 ␣ (PGC1-␣)-dependent myokine, and seems to be capable of inducing white adipose tissue browning and uncoupling protein 1 expression. 62 PGC-1␣ is best known to regulate energy metabolism; however, it has other beneficial actions, such as control of mitochondrial biogenesis and oxidative metabolism in many cell types. 63 PGC-1␣ is induced in muscles by exercise and stimulates mitochondrial biogenesis, angiogenesis, and fiber-type switching. 64 63 Recent research indicated that, in an obese rodent model, FNDC5 treatment improved glucose tolerance and elevated expression of mitochondrial genes that increase oxygen consumption. 63, 65 Exercise may increase plasma irisin levels. Results from several studies suggested that plasma irisin levels were elevated in rodents and humans following exercise. 63, 66, 67 Bostrom et al 63 demonstrated an increase of plasma irisin level in mice after 3 weeks of voluntary wheel running, and a twofold increase of circulating plasma irisin level in healthy adults compared to the nontraining group after 10 weeks of endurance exercise. In addition, irisin levels increased in response to acute exercise. 63 Our recent laboratory data on 8 weeks of aerobic exercise and resistance exercise in obese humans demonstrated a positive correlation between the circulating irisin level and changes of muscle mass, and a negative correlation between the circulating irisin level and changes of fat mass and body fat percentage. 67 Despite differences in results, both previous studies and our study consistently demonstrated an increased level of irisin following exercise. 66 Therefore, irisin has potential as a therapeutic agent. Further study is required to investigate the changes in irisin levels and its protective role in obesity and diabetes following exercise.
Fibroblast growth factor 21
FGF-21, an endocrine hormone, plays an important role in the progression of metabolic regulation by controlling glucose and lipid metabolism. [68] [69] [70] FGF-21 is expressed in peripheral tissues, such as white adipose tissue, liver, pancreas, and skeletal muscle. 71 FGF-21 levels increased during starvation and the ketogenic state, and decreased after refeeding. 72 Administration of FGF-21 reduced plasma glucose and triglycerides, and increased insulin sensitivity in diabetic rodents. 73 Walsh and coworkers 74 also demonstrated that FGF-21 is produced by skeletal muscle. Several studies determine FGF-21 as a key factor for downstream target of PPAR-␣. FGF-21 may thus play an important role in metabolism. Recent studies suggested that FGF-21 levels were elevated in metabolic diseases, including insulin resistance, metabolic syndrome, and type 2 diabetes. Hojman et al's 70 study demonstrated an increased FGF-21 expression in muscle and plasma in response to insulin stimulation. Additionally, FGF-21-null mice not only failed to express PGC-1␣, but also had impaired gluconeogenesis and ketogenesis. Recent studies showed that FGF-21 is elevated after exercise. In healthy humans, serum FGF-21 levels increased after 2 weeks of treadmill exercise. 75 Serum FGF-21 levels also increased in mice and humans by a single bout of acute exercise. 76 The increase in FGF-21 was accompanied by an increase in lipolytic response, leading to the release of free fatty acid and glycerol. Data of these studies might have suggested that increased serum FGF-21 levels lead to increased lipolysis and decreased glucose levels after a high-intensity exercise. 75, 76 According to our unpublished data, 8 weeks of ladder climbing exercise increased FGF-21 level in the soleus and extensor digitorum longus muscles in type 2 diabetes rats. FGF-21 might be elevated in response to exercise, greatly affecting metabolic mechanisms. Therefore, further study is required to investigate changes in the FGF-21 level in response to the duration or type of exercise, for effective treatment of diabetes.
7.
Secreted protein acidic and rich in cysteine SPARC, also known as BM-40 was initially identified in bone and hence was named osteonectin initially. 77 For a decade, intense studies on the effect of SPARC on various pathological conditions of organs such as the liver and kidney were conducted. 78 SPARC acts as a counteradhesive and a modulator of cell-surface interaction during tissue renewal and remodeling, which requires regulation of cell-matrix or cell-cell contact. 79 Most studies on regulation of SPARC expression and function are related to bone. During osteogenesis, SPARC links the organic and mineral phases of the bone extracellular matrix. 80 However, recent studies revealed that SPARC is also found in myoblasts, myotubes, and muscle fibers, where its levels increase during muscle development and regeneration. 81 Importantly, SPARC secretion was found to increase in muscles not only during regeneration, but also following resistance exercise and muscle hypertrophy. 82 A single bout of exercise increases secretion of SPARC in mice. Levels of SPARC in the gastrocnemius muscle were significantly increased after a single bout of exercise, specifically around the plasma membrane. However, SPARC levels decreased immediately after exercise. In addition, SPARC was increased in the serum of young healthy men immediately after a single bout of cycling at 70% VO 2 max for 30 minutes, but gradually decreased to the resting level. However, 4 weeks of training at 70% VO 2 max resulted in a significant increase in serum SPARC, with no changes in the resting state. 83 SPARC is currently identified as one of the myokines that reduces fat accumulation and is involved in glucose metabolism. 84, 85 First, SPARC is involved in the regulation of adipocyte differentiation and adipose tissue turnover 84 by activating the Wnt/␤-caternin pathway that inhibits adipogenesis and enhances osteoblastogenesis. [86] [87] [88] In addition, SPARC, by having a dose-dependent inhibitory effect on adipogenesis and formation of osteoblast, was also enhanced in a dose-dependent fashion. Primary culture of SPARC-null mice cells showed increased adipocyte and fat accumulation as compared to wild-type mice. 84 SPARC decreased adipogenesis by regulating expression, deposition, and organization of extracellular matrix protein rather than by interfering adipogenesis directly. It modulates monoclonal anticellular fibronectin and antimouse laminin production in the extracellular matrix during adipogenesis, where fibronectin inhibits adipogenesis and laminin enhances adipogenesis. 84 These changes inhibit the rearrangement of F-actin and stress fibers form the fiber-like preadipocyte cell structure, which weakens during adipogenesis to allow fat accumulation. 84 SPARC is also involved in glucose metabolism via the AMPK signaling pathway. The AMPK signaling pathway has been identified as an energy-sensing pathway that plays a critical role in regulating glucose and fat metabolism in skeletal muscle during exercise. 89, 90 It stimulates glucose uptake by increasing glucose transporter translocation. 91, 92 Further study is needed to investigate the change in SPARC level according to the exercise duration, to effectively regulate glucose and fat metabolism.
Conclusion
Small changes induced by exercise can create a ripple effect of benefits to the entire body. It is well known that exercise satisfies essential requirements for a healthy life. Regular physical activity or exercise can prevent chronic diseases, such as cardiovascular diseases, metabolic diseases, and cognitive disorders. Findings from previous studies indicated that exercise-induced myokines might be the potential candidates to provide beneficial effects by stimulating metabolic pathways, improving glucose uptake, improving fat oxidation, and regulating skeletal muscle regeneration. Based on a review of the literature, we provide new insights into the role of exercise-induced myokines as important potential therapeutic factors for the prevention of metabolic diseases. Further research is clearly required to identify how exercise-induced myokines relate to chronic or metabolic diseases, including type 2 diabetes, obesity, and muscle atrophy.
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